文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19不影响ARDS治疗后的功能状态

COVID-19 does not influence functional status after ARDS therapy.
PubMed 文献 · Crit Care · 2023-02-05
一句话结论在随机多中心试验中,COVID-19所致ARDS与非COVID-19所致ARDS的180天死亡率和Barthel指数残疾程度无差异,第5天SOFA评分是两组高残疾的独立危险因素。

该研究纳入144例由COVID-19或其他原因引起的ARDS患者,来自一项随机多中心试验。收集ICU治疗期间及入组后180天内的数据,用SOFA评分变化量化疾病严重程度,用Barthel指数在第1、28、90、180天评估残疾。结果显示,第5天SOFA评分是两组高残疾的独立危险因素,非COVID组前5天评分动态显著影响残疾;COVID组与非COVID组180天死亡率和Barthel指数评估的损伤无差异。结论认为,前5天器官功能障碍的缓解显著影响长期发病率,COVID-19所致ARDS与死亡率或发病率增加无关。

要点

  • 第5天SOFA评分是COVID-19组和非COVID-19组高残疾的独立危险因素。
  • 非COVID-19组中,前5天SOFA评分动态显著影响残疾。
  • COVID-19组与非COVID-19组180天死亡率无差异。
  • COVID-19组与非COVID-19组Barthel指数评估的损伤无差异。
  • 前5天器官功能障碍的缓解显著影响长期发病率。

适用人群与场景

  • 144例由COVID-19或其他原因引起的急性呼吸窘迫综合征患者,来自一项随机多中心试验。

研究设计与关键结果

  • 研究类型为随机多中心试验,纳入144例COVID-19或非COVID-19所致ARDS患者,收集ICU治疗期间及入组后180天内数据。
  • 第5天SOFA评分是两组高残疾的独立危险因素。
  • 非COVID组前5天SOFA评分动态显著影响残疾。
  • COVID-19组与非COVID-19组180天死亡率无差异。
  • COVID-19组与非COVID-19组Barthel指数评估的损伤无差异。

证据类型、等级与局限

  • 证据类型:随机多中心试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论认为,前5天器官功能障碍的缓解显著影响长期发病率;COVID-19所致ARDS与死亡率或发病率增加无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Health-related quality of life after surviving acute respiratory distress syndrome has come into focus in recent years, especially during the coronavirus disease 2019 pandemic.

OBJECTIVES: A total of 144 patients with acute respiratory distress syndrome caused by COVID-19 or of other origin were recruited in a randomized multicenter trial.

METHODS: Clinical data during intensive care treatment and data up to 180 days after study inclusion were collected. Changes in the Sequential Organ Failure Assessment score were used to quantify disease severity. Disability was assessed using the Barthel index on days 1, 28, 90, and 180.

MEASUREMENTS: Mortality rate and morbidity after 180 days were compared between patients with and without COVID-19. Independent risk factors associated with high disability were identified using a binary logistic regression.

MAIN RESULTS: The SOFA score at day 5 was an independent risk factor for high disability in both groups, and score dynamic within the first 5 days significantly impacted disability in the non-COVID group. Mortality after 180 days and impairment measured by the Barthel index did not differ between patients with and without COVID-19.

CONCLUSIONS: Resolution of organ dysfunction within the first 5 days significantly impacts long-term morbidity. Acute respiratory distress syndrome caused by COVID-19 was not associated with increased mortality or morbidity.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Bernard A, Serna-Higuita LM, Martus P, et al. COVID-19 does not influence functional status after ARDS therapy. Crit Care. 2023. PMID: 36740717. doi:10.1186/s13054-023-04330-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。